Logo image of RELY

REMITLY GLOBAL INC (RELY) Stock Fundamental Analysis

NASDAQ:RELY - Nasdaq - US75960P1049 - Common Stock - Currency: USD

15.79  -0.71 (-4.3%)

After market: 15.8 +0.01 (+0.06%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to RELY. RELY was compared to 101 industry peers in the Financial Services industry. No worries on liquidiy or solvency for RELY as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, RELY is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

RELY had negative earnings in the past year.
RELY had a positive operating cash flow in the past year.
RELY had negative earnings in each of the past 5 years.
RELY had negative operating cash flow in 4 of the past 5 years.
RELY Yearly Net Income VS EBIT VS OCF VS FCFRELY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

The Return On Assets of RELY (-0.41%) is worse than 78.22% of its industry peers.
RELY's Return On Equity of -0.63% is on the low side compared to the rest of the industry. RELY is outperformed by 77.23% of its industry peers.
Industry RankSector Rank
ROA -0.41%
ROE -0.63%
ROIC N/A
ROA(3y)-10.47%
ROA(5y)-9.32%
ROE(3y)-17.19%
ROE(5y)-15.62%
ROIC(3y)N/A
ROIC(5y)N/A
RELY Yearly ROA, ROE, ROICRELY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

RELY has a better Gross Margin (65.86%) than 79.21% of its industry peers.
In the last couple of years the Gross Margin of RELY has grown nicely.
The Profit Margin and Operating Margin are not available for RELY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.19%
GM growth 5Y3.35%
RELY Yearly Profit, Operating, Gross MarginsRELY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

8

2. Health

2.1 Basic Checks

RELY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RELY has more shares outstanding
The number of shares outstanding for RELY has been increased compared to 5 years ago.
RELY has a better debt/assets ratio than last year.
RELY Yearly Shares OutstandingRELY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RELY Yearly Total Debt VS Total AssetsRELY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

RELY has an Altman-Z score of 6.36. This indicates that RELY is financially healthy and has little risk of bankruptcy at the moment.
RELY's Altman-Z score of 6.36 is amongst the best of the industry. RELY outperforms 90.10% of its industry peers.
The Debt to FCF ratio of RELY is 0.01, which is an excellent value as it means it would take RELY, only 0.01 years of fcf income to pay off all of its debts.
RELY has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. RELY outperforms 93.07% of its industry peers.
RELY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, RELY belongs to the top of the industry, outperforming 91.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 6.36
ROIC/WACCN/A
WACC8.75%
RELY Yearly LT Debt VS Equity VS FCFRELY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.78 indicates that RELY has no problem at all paying its short term obligations.
RELY has a Current ratio of 2.78. This is amongst the best in the industry. RELY outperforms 81.19% of its industry peers.
RELY has a Quick Ratio of 2.78. This indicates that RELY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of RELY (2.78) is better than 82.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 2.78
RELY Yearly Current Assets VS Current LiabilitesRELY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

RELY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 95.08%, which is quite impressive.
RELY shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.37%.
Measured over the past years, RELY shows a very strong growth in Revenue. The Revenue has been growing by 58.44% on average per year.
EPS 1Y (TTM)95.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)34.37%
Revenue growth 3Y40.21%
Revenue growth 5Y58.44%
Sales Q2Q%34.37%

3.2 Future

RELY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 89.31% yearly.
The Revenue is expected to grow by 19.15% on average over the next years. This is quite good.
EPS Next Y142.05%
EPS Next 2Y84.76%
EPS Next 3Y72.88%
EPS Next 5Y89.31%
Revenue Next Year26.17%
Revenue Next 2Y23.36%
Revenue Next 3Y21.15%
Revenue Next 5Y19.15%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RELY Yearly Revenue VS EstimatesRELY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
RELY Yearly EPS VS EstimatesRELY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RELY. In the last year negative earnings were reported.
RELY is valuated quite expensively with a Price/Forward Earnings ratio of 58.79.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RELY indicates a slightly more expensive valuation: RELY is more expensive than 78.22% of the companies listed in the same industry.
RELY is valuated expensively when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 58.79
RELY Price Earnings VS Forward Price EarningsRELY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RELY is valued a bit more expensive than 71.29% of the companies in the same industry.
RELY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. RELY is cheaper than 77.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.1
EV/EBITDA 183.51
RELY Per share dataRELY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

RELY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RELY's earnings are expected to grow with 72.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y84.76%
EPS Next 3Y72.88%

0

5. Dividend

5.1 Amount

RELY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REMITLY GLOBAL INC

NASDAQ:RELY (8/1/2025, 8:00:02 PM)

After market: 15.8 +0.01 (+0.06%)

15.79

-0.71 (-4.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners78.69%
Inst Owner Change-0.23%
Ins Owners3.24%
Ins Owner Change-0.91%
Market Cap3.22B
Analysts82.22
Price Target29.09 (84.23%)
Short Float %7.01%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)190.25%
Min EPS beat(2)66.06%
Max EPS beat(2)314.43%
EPS beat(4)4
Avg EPS beat(4)132.83%
Min EPS beat(4)37.61%
Max EPS beat(4)314.43%
EPS beat(8)7
Avg EPS beat(8)71.64%
EPS beat(12)9
Avg EPS beat(12)40.76%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.22%
Min Revenue beat(2)0.48%
Max Revenue beat(2)1.97%
Revenue beat(4)3
Avg Revenue beat(4)1.19%
Min Revenue beat(4)-0.54%
Max Revenue beat(4)2.86%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)8
Avg Revenue beat(12)1.36%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.68%
PT rev (3m)5.65%
EPS NQ rev (1m)-39.86%
EPS NQ rev (3m)29.95%
EPS NY rev (1m)-12.97%
EPS NY rev (3m)174.17%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 58.79
P/S 2.37
P/FCF 9.1
P/OCF 8.38
P/B 4.45
P/tB 4.88
EV/EBITDA 183.51
EPS(TTM)-0.03
EYN/A
EPS(NY)0.27
Fwd EY1.7%
FCF(TTM)1.74
FCFY10.99%
OCF(TTM)1.88
OCFY11.94%
SpS6.65
BVpS3.55
TBVpS3.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.41%
ROE -0.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.86%
FCFM 26.09%
ROA(3y)-10.47%
ROA(5y)-9.32%
ROE(3y)-17.19%
ROE(5y)-15.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.19%
GM growth 5Y3.35%
F-Score7
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.18
Cap/Depr 153.25%
Cap/Sales 2.23%
Interest Coverage N/A
Cash Conversion 2811.74%
Profit Quality N/A
Current Ratio 2.78
Quick Ratio 2.78
Altman-Z 6.36
F-Score7
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)90.84%
Cap/Depr(5y)93.25%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next Y142.05%
EPS Next 2Y84.76%
EPS Next 3Y72.88%
EPS Next 5Y89.31%
Revenue 1Y (TTM)34.37%
Revenue growth 3Y40.21%
Revenue growth 5Y58.44%
Sales Q2Q%34.37%
Revenue Next Year26.17%
Revenue Next 2Y23.36%
Revenue Next 3Y21.15%
Revenue Next 5Y19.15%
EBIT growth 1Y94.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year454.5%
EBIT Next 3Y101.59%
EBIT Next 5Y81.86%
FCF growth 1Y331.99%
FCF growth 3YN/A
FCF growth 5Y170.09%
OCF growth 1Y365.04%
OCF growth 3YN/A
OCF growth 5Y87.29%